(Date:11/5/2009)...PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD ) ...ng at the following investor conferences, and invi... Credit Suisse Healthcare Conference, P... 2009 at 10 a.m. Mountain Time, N... Tuesday, 1 December, 2009 at 10.45...
(Date:11/5/2009)...Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone...he "Company") today announced,that the Company pla... on,Monday, November 9, 2009, after the market clo... call at 5:00 pm ET on November 9, 2009,to discuss... the call by,dialing 1-888-713-4211 or 1-617-213-4...
(Date:11/4/2009)...an Anthrax Vaccine Program must be stopped. Scott... "A Call to Arms:2009 Edition" and the o...y: The Human Anthrax Vaccine Story" to inform...top secret government science turned into for-prof...o its victims. It is available for world-wide lic...
(Date:11/4/2009)... Nektar Therapeutics (Nas...for the third quarter ended September 30, 2009. ,...2009 improved to $31.0 million or $0.33 per share,...40 per share in the third quarter of 2008. ,...rating efficiencies as compared to a year ago. To...
Breaking Biology Technology:Cepheid to Webcast Upcoming Financial Presentations 2BMP Sunstone to Report Third Quarter 2009 Financial Results 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10...lif., May 8 Onyx,Pharmaceuticals, Inc. (Nasdaq: ... Bank of America Health Care Conference on Thursda...parties may access a live webcast of the,presentat...wt/page/event_calendar , It is recommended that l...ter and download any necessary software. For those...
... Calif., May 8 Beckman Coulter,Inc. (NYSE: BEC )...of,products that simplify, automate, and innovate ...ul Glyer, Beckman Coulter,s Senior Vice President,... the following,conferences:, (Logo: http://ww... Bank of America 2008 Healthcare Conference on Wed...
...., May 8 BioSpace, the world,s leading,online bio...pany, unveiled,this morning the 2008 Bio NC(TM) Ho... Carolina., (Photo: http://www.newscom.com/cgi-b...ewscom.com/cgi-bin/prnh/20080222/CLF013LOGO ), T...pharmaceutical and,medical device communities in R...
Other Biology Technology:Beckman Coulter to Present at Upcoming Healthcare Conferences 2BioSpace Launches 6th Edition of Bio NC(TM) Hotbed Campaign 2Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Goat Anti-SPFH2 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Als2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Kusabira Orange Monoclonal Antibody, Unconjugated, Clone 2G9 from MBL International
Biology Products: